e-learning
resources
Vienna 2003
Sunday 28.09.2003
Recognition, management and assessment of asthma including severe asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled nitric oxide and inhaled steroids in patients with stable asthma in primary care
W. A. Biernacki, H. M. Biernacka, S. A. Kharitonov, P. J. Barnes (London, United Kingdom)
Source:
Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma
Session:
Recognition, management and assessment of asthma including severe asthma
Session type:
Oral Presentation
Number:
193
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. A. Biernacki, H. M. Biernacka, S. A. Kharitonov, P. J. Barnes (London, United Kingdom). Exhaled nitric oxide and inhaled steroids in patients with stable asthma in primary care. Eur Respir J 2003; 22: Suppl. 45, 193
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002
The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012
Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Exhaled nitric oxide in children with severe asthma
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012
Exhaled nitric oxide as a predictor of exacerbations of asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 307s
Year: 2004
Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study
Source: Eur Respir J 2014; 44: 1705-1707
Year: 2014
Exhaled nitric oxide and carbon monoxide are not markers of disease activity in asthma patients on reducing doses of inhaled steroids: a longitudinal study
Source: Eur Respir J 2001; 18: Suppl. 33, 337s
Year: 2001
Exhaled nitric oxide in the assessment of asthma control
Source: Eur Respir J 2007; 30: Suppl. 51, 18s
Year: 2007
Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma
Source: Eur Respir J 2010; 35: 1221-1227
Year: 2010
Exhaled nitric oxide (eNO): an early indicator of asthma relapse in children
Source: Eur Respir J 2005; 26: Suppl. 49, 42s
Year: 2005
Exhaled nitric oxide and clinical phenotype of childhood asthma
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011
The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001
Exhaled nitric oxide and pulmonary function tests in children with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 759s
Year: 2007
Fractionated exhaled nitric oxide in COPD patients
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Exhaled nitric oxide and COPD
Source: Eur Respir J 2010; 36: 692
Year: 2010
Exhaled nitric oxide is related to asthma control but not severity
Source: Eur Respir J 2004; 24: Suppl. 48, 260s
Year: 2004
Exhaled nitric oxide and cough variant asthma
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009
Stability of exhaled nitric oxide (F
E
NO) in patients with severe, steroid-dependent asthma
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008
Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept